Kontafarma China Holdings Ltd

01312

Company Profile

  • Business description

    Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs active pharmaceutical ingredients and API intermediates in the PRC, operating of fitness centres and provision of consultation services for fitness and health activities and operating of the franchise business for royalty fee income. The operating segments include the pharmaceutical business and the Fitness business. The majority of its revenue derives from the pharmaceutical business segment.

  • Contact

    30 Harbour Road
    Room 12A 09-20, 12th Floor, Sun Hung Kai Centre
    Wanchai
    Hong Kong
    HKG

    T: +852 27316500

    http://www.kontafarma.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    688

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,963.5029.200.33%
CAC 407,800.8833.70-0.43%
DAX 4023,970.36247.14-1.02%
Dow JONES (US)44,837.5664.36-0.14%
FTSE 1009,081.4438.87-0.43%
HKSE25,562.13173.780.68%
NASDAQ21,178.5870.270.33%
Nikkei 22540,998.27457.96-1.10%
NZX 50 Index12,928.0117.270.13%
S&P 5006,389.771.130.02%
S&P/ASX 2008,697.7030.800.36%
SSE Composite Index3,597.944.280.12%

Market Movers